Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects

Diabetes

Volumn 47, Issue 2, 1998, Pages 290-293

  Calles Escandon, Jorge ^a   Mirza, Shirwan A ^a   Sobel, Burton E ^a   Schneider, David J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INTRALIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031937736     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.2.290     Document Type: Article

References (25)

1. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3:463-524, 1987
2. Auwerx J, Bouillon R, Collen D, Geboers J: Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 8:68-72, 1988
3. Garcia-Frade LJ, De La Galle H, Torrrado MC, Lara JI, Cuellar L, Garcia Avello A: Hypofibrinolysis associated with vasculopathy in non-insulin dependent diabetes mellitus. Arteriosclerosis 59:51-59, 1988
4. Almer LO: Fibrinolytic disorders in diabetes mellitus. Diabete Metab 14:519-522, 1990
5. Juhan-Vague I, Thompson SG, Jespersen J: Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris: the ECAT Angina Pectoris Study Group. Arteriosicler Thromb 13:1865-1873, 1993
6. McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE: Factors responsible for impaired flbrinolysis in obese subjects and NIDDM patients. Diabetes 43:104-109, 1994
7. Calles-Escandon J, Sobel B, Ballor D, Harvey-Berino J, Ades P, Tracy R: Amelioration of the inhibition of flbrinolysis in elderly obese subjects by moderate energy intake restriction. Am J Clin Nutr 64:7-11, 1996
8. Ehrman DA, Schneider DJ, Sobel BE, Imperial J, Rosenfleld RL, Polonsky KS: Troglitazone improves defects in insulin action, insulin secretion, ovarian steroiogenesis and flbrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2108-2116, 1997
9. DeFronzo RA: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
10. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
11. Alessi MC, Juhan-Vague I, Kooistra T, DeClerck PJ, Collen D: Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line HepG2. Thromb Haemost 60:491-494, 1988
12. Schneider DJ, Sobel BE: Augmentation of synthesis of plasminogen activator inhibitor type-1 by insulin and insulin-like growth factor type-1: implications for vascular disease in hyperinsulinemic states. Proc Natl Acad Sci USA 88:9959-9963, 1991
13. Kooistra T, Bosma PJ, Tons HAM, Van Den Berg AP, Meyer P, Princen HMG: Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. Thromb Haemost 62:723-728, 1989
14. Schneider DJ, Absher PM, Ricci MA: Dependence of augmentation of arterial endothelial cell expression of plasminogen activator inhibitor type 1 by insulin on soluble factors released from vascular smooth muscle cells. Circulation 96:2868-2876, 1997
15. Nordt TK, Sawa H, Fujii S, Sobel BE: Induction of plasminogen activator inhibitor type I (PAH) by proinsulin and insulin in vivo. Circulation 91:764-770, 1995
16. Vuorinen-Markkola H, Puhakainen I, Yki-Jarvinen H: No evidence for short-term regulation of plasminogen activator inhibitor type 1 activity by insulin in man. Circulation 91:764-770, 1995
17. Grant PJ, Kruithof E, Felley CP, Felber IP, Bachman F: Short-term infusions of insulin, triacylglycerol and glucose do not cause acute increases in plasminogen activator inhibitor-1 concentrations in man. Clin Sci 79:513-516, 1990
18. Schneider DJ, Sobel BE: Synergistic augmentation of expression of plasminogen activator inhibitor type 1 induced by insulin, very low density lipoproteins, and fatty acids. Coronary Artery Disease 7:813-817, 1996
19. National Diabetes Data Group: Classification of diabetes mellitus and other states of glucose intolerance. Diabetes 28:1039-1054, 1979
20. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
21. Starr JL, Horwitz DL, Rubenstein AH: Insulin, proinsulin and C-peptide. In Methods of Hormone Radioimmunoassay. 2nd ed Jaffee BM, Behrman HR, Eds. San Diego, CA, Academic, 1979, p. 613-642
22. Schneider DJ, Nordt TK, Sobel BE: Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells. Diabetes 41:890-895, 1992
23. Nordt TK, Klassen KJ, Schneider DJ, Sobel BE: Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local flbrinolysis. Arterioscler Thromb 13:1822-1828, 1993
24. Cortellaro M, Cotrancesco E, Boschetti C, Mussoni L, Donati MB, Cardillo M, Catalano M, Gabrielli L, Lombardi B, Specchia G: Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients: a case-control study. The PLAT Group. Arterioscler Thromb 13:1412-1417, 1993
25. Malmberg K, Bavenholm P, Hamsten A: Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age. J Am Coll Cardiol 24:424-429, 1994